Dr. Mendel Tuchman
| M.D., Tel-Aviv University, Sackler School of Medicine, 1979 |
| Children's Research Institute, Children's National Medical Center, Washington D.C. |
My laboratory is engaged in translational research of genes and proteins involved
in nitrogen metabolism, in order to better
understand and treat patients with urea cycle disorders and hyperammonemia.
We are studying the molecular and cell biology and
biochemistry of the urea cycle proteins. After solving the crystal structure
of human ornithine transcarbamylase (OTC) deficiency and
exploring structure/function correlations, we are now investigating the mitochondrial
ornithine transporter (ORNT1) as well as the
citrin (glutamate/aspartate) transporter and interactions with the OTC enzyme.
Following the cloning of two mammalian
N-acetylglutamate (NAGS) genes and the identification of mutations in the human
gene that cause hyperammonemia, we are now
working on the characterization of the "mature" recombinant enzyme(s)
and the 3-D structure. We will also be investigating the
biological role of NAGS and its possible interactions with other components
of the urea cycle and we are working to create an
animal model of NAGS deficiency.
Caldovic L, Tuchman M (2003) N-acetylglutamate and its role through evolution. Biochem J 372:279-290
Caldovic L, Morizono M, Panglao M, Cheng SF, Packman S, Tuchman M (2003) Null
mutations in the N-acetylglutamate synthase gene associated with acute
neonatal disease and hyperammonemia. Hum genet 112:364-368
Caldovic L, Morizono H, Panglao MG, Gallegos R, Yu X, Shi D, Malamy MH, Norma
M. Allewell NM, Tuchman M (2002) Cloning and expression of the human
N-acetylglutamate synthase gene. Biochem Biophys Res Commun 299:581-586
Caldovic L, Morizono H, Yu X, Thompson M, Shi D, Gallegos R, Allewell NM,
Malamy MH, Tuchman M (2002) Identification, cloning and expression of the mouse
N-acetylglutamate synthase gene. Biochem J 364:825-831
Shi D, Gallegos R, DePonte J, Morizono H, Yu X, Allewell NM, Malamy M, Tuchman
M (2002) Crystal structure of a new transcrbamylase from the anaerobic
bacterium Bacteroides fragilis at 2.0 Å resolution. J Mol Biol 320:899-908
Mavinakere M, Morizono H, Shi D, Allewell NM, Tuchman M (2001) The clinically
variable R40H mutant ornithine transcarbamylase shows cytosolic degradation
of
the precursor protein in CHO cells. J Inherit Metab Dis 24:614-622
Shi D, Morizono H, Yu X, Tong L, Allewell NM, Tuchman M (2001) Crystallization
and preliminary x-ray crystallographic studies of wild-type human ornithine
transcarbamylase and two naturally occurring mutants at position 277. Acta Crystallogr
D Biol Crystallogr 57:719-721
Shi D, Morizono H, Yu X, Allewell NM, Tuchman M (2001) Human ornithine transcarbamylase:
Crystallographic insights into substrate recognition and
conformational change. Biochem J 354:501-509
Augustin L, Mavinakere M, Morizono H, Tuchman M (2000) Expression of wild
type and mutant human ornithine transcarbamylase genes in Chinese hamster ovary
cells and study of dominant negative effect. Pediatr Res 48:842-846
Shi D, Morizono H, Aoyagi M, Tuchman M, Allewell NM (2000) Crystal structure
of human ornithine transcarbamoylase complexed with carbamoyl phosphate and
L-norvaline at 1.9 Å resolution. Proteins 39:271-277